The quantitative and histological demonstration of pathogenic synergy between Escherichia coli and Bacteroides fragilis in guinea-pig wounds

Journal of Medical Microbiology
M J Kelly

Abstract

Known numbers of standard strains of Escherichia coli and Bacteroides fragilis were inoculated together into surgical incision in guinea-pigs. Histological and quantitative bacteriological proof is presented that pathogenic synergy occurred in vivo with copious pus formation when combinations of subinfective doses of each organism were inoculated. A further series of experiments showed that the amounts and ratios of E. coli and B. fragilis in the septic inocula were critical, and that the resultant pus contained equal numbers of both the aerobic and the anaerobic organisms. This model may be suitable for the experimental validation of short-term regimens of prophylactic antibiotics in surgery; the present results seem to have important therapeutic implications.

Citations

Oct 1, 1983·European Journal of Clinical Microbiology·F MoesgaardT Justesen
Feb 1, 1983·European Journal of Clinical Microbiology·J C HagenT Hashimoto
Dec 1, 1982·European Journal of Clinical Microbiology·J C HagenT Hashimoto
Jan 1, 1984·Antonie van Leeuwenhoek·D M MacLarenJ A Kaan
Oct 1, 1984·Zentralblatt Für Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology·A C Rodloff, H Hahn
Aug 1, 1981·The Journal of Applied Bacteriology·T G Mason, G Richardson
Jan 1, 1983·Scandinavian Journal of Infectious Diseases·A Schwan, D Danielsson
May 14, 2016·Journal of Molecular Biology·Wei Hong TayKimberly A Kline
May 17, 2006·Anaerobe·Andrew B Onderdonk
Aug 1, 1997·The Annals of Otology, Rhinology, and Laryngology·A O IbekweA Benayam
Mar 1, 1990·The British Journal of Surgery·D Kingston, D V Seal
Feb 1, 1983·Clinical Otolaryngology and Allied Sciences·G G BrowningI T Calder
Aug 1, 1985·Journal of Clinical Pathology·J J Finlay-Jones, M Reznikov
Jan 1, 1987·Critical Reviews in Microbiology·I Brook
Jun 16, 2001·The Journal of Bone and Joint Surgery. American Volume·K J HendricksB J Gainor
Apr 1, 1980·Acta Pathologica Et Microbiologica Scandinavica. Section B, Microbiology·P O Nyström
Oct 1, 1985·Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section B, Microbiology·T WadströmS Hjertén

Related Concepts

Bacteroides fragilis
Bacteroides Infections
Alkalescens-Dispar Group
Escherichia Coli Infections
Cavia porcellus
Pus
Wound Infection

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.